Repurposing anticancer drugs for the management of COVID-19

Since its outbreak in the last December, coronavirus disease 2019 (COVID-19) caused by SARS-CoV-2 has rapidly spread worldwide at a pandemic proportion and thus is regarded as a global public health emergency. The existing therapeutic options for COVID-19 beyond the intensive supportive care are lim...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Eur J Cancer
Main Authors: El Bairi, Khalid, Trapani, Dario, Petrillo, Angelica, Le Page, Cécile, Zbakh, Hanaa, Daniele, Bruno, Belbaraka, Rhizlane, Curigliano, Giuseppe, Afqir, Said
Formato: Artigo
Idioma:Inglês
Publicado em: Elsevier Ltd. 2020
Assuntos:
Review
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7508523/
https://ncbi.nlm.nih.gov/pubmed/33125946
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ejca.2020.09.014
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados